Does TYK2/JAK1 Show Potential in Inflammatory Diseases? - Poll - MDSpire

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

  • By

  • Andrea Surnit

  • July 6, 2026

  • 3 min

Share

Original Source(s)

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

  • by Andrea Surnit

  • July 6, 2026

Related Content

Hair Repigmentation Reported With Baricitinib in Canities Subita

A single case suggests a possible benefit, but confounding factors and the off-label setting temper the conclusions.

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.

Gene expression profiling of dendritic cell tolerance dysfunction in women with systemic lupus erythematosus